Very excited to once again join the fantastic Cancer Immunotherapy conference at #CIMT2025. Very much looking forward to three days of learning, connecting and sharing insights from our own research at #BoppLab!
12.05.2025 08:35 — 👍 0 🔁 0 💬 0 📌 0
Technology-driven biomedical research at CeMM Research Center for Molecular Medicine & MedUni Vienna #cancer #immunology #bioinformatics #AI #singlecell #CRISPR
Cell Reprogramming in Hematopoiesis and Immunity, Lund University, Sweden. Tweets by Filipe Pereira (signed FP) and Malavika Nair (for Pereira lab). https://pereiralab.com/
We develop NK-cell based cancer immunotherapy. Lab nodes at the University of Oslo, Norway and Karolinska Institute, Sweden.
#newPI at @WeizmannScience | study immunity through the lens of antigen presentation | Dan Littman alum
https://www.kedmilabweizmann.com
Die DFG ist die größte Forschungsförderorganisation und die Selbstverwaltungsorganisation der Wissenschaft in Deutschland.
www.dfg.de
Impressum: https://www.dfg.de/de/service/kontakt/impressum
Social Media-Netiquette: https://www.dfg.de/de/service/presse
Neurologist and Immunologist at University Heidelberg and DKFZ with a focus on immunotherapy and cellular therapy of brain tumors and CNS autoimmunity
Neurologist, Chair of Neurology
Brain Tumor Immunotherapy
@dkfz.bsky.social
@platten-lab.bsky.social
@uniheidelberg.bsky.social
Medical Faculty Mannheim
Founder Tcelltech
President @eanoassociation.bsky.social
Ambassador for the @erc.europa.eu
The Association for Cancer Immunotherapy CIMT is a not-for-profit information and education platform that fosters the development and translation of cancer immunotherapies .
Group Leader in Mainz, Interested in Tumor Immunology, Tumor Acidosis and Immunotherapy
Cutting-edge research, news, commentary, and visuals from the Science family of journals. https://www.science.org
An open-access @natureportfolio.bsky.social journal publishing high quality primary research, reviews and commentary in all areas of the biological sciences since 2018.
https://www.nature.com/commsbio/
An open access @NaturePortfolio journal publishing high-quality primary research articles, reviews and commentary in all areas of the chemical sciences.
nature.com/commschem/
An open access @natureportfolio.bsky.social journal publishing high quality primary research, reviews, and commentary in Earth, environmental, and planetary science.
nature.com/commsenv/
The multi-disciplinary engineering journal from the Nature Portfolio. Fully open access. You can read all our content here for free: https://www.nature.com/commseng/
An open access journal from Nature Portfolio publishing important advances in all areas of materials science.
A selective open access journal from @NaturePortfolio publishing research, reviews & commentary across clinical, translational & public health research fields. nature.com/commsmed
Communications Physics is an open access journal from Nature Portfolio publishing high-quality research, reviews and commentary in all areas of the physical sciences.
https://www.nature.com/commsphys/
Communications Psychology is a selective, peer reviewed, open access journal in the @natureportfolio.bsky.social, publishing high-quality research, reviews and commentary across psychology.
https://www.nature.com/commspsychol/
A Nature journal dedicated to presenting the very best research across the disciplines of astronomy, astrophysics, cosmology and planetary science.📡
www.nature.com/natastron
Publishing the best of biotech science and business. Find us on Twitter, Facebook & Instagram. Part of @natureportfolio.nature.com.
